H. Shepard
Oprichter bij Enosi Life Sciences Corp.
Actieve functies van H. Shepard
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Directeur/Bestuurslid | 16-08-2018 | - |
Hoofd Techniek/Wetenschap/O&O | 16-08-2018 | - | |
Oprichter | 16-08-2018 | - | |
President | 16-08-2018 | - | |
Algemeen Directeur | 16-08-2018 | 09-11-2021 |
Loopbaan van H. Shepard
Eerdere bekende functies van H. Shepard
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 15-06-2009 | 01-02-2017 |
Receptor BioLogix, Inc.
Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Hoofd Techniek/Wetenschap/O&O | 27-05-2003 | 02-01-2008 |
Oprichter | 27-05-2003 | 02-01-2008 | |
President | 27-05-2003 | 02-01-2008 | |
NewBiotics, Inc.
NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology NewBiotics, Inc. develops pharmaceutical drugs to treat cancer and infectious disease. It applies its Enzyme Catalyzed Therapeutic Activation technology to develop pharmaceuticals that transform drug resistance into therapeutic advantage. The company was founded by H. Michael Shepard and Geoffrey Myles Wahl in 1997 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-1997 | 01-01-2008 |
President | 01-01-1997 | 01-01-2008 | |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Hoofd Techniek/Wetenschap/O&O | 01-01-1992 | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-1980 | - |
NEVIS BRANDS INC. | Directeur/Bestuurslid | 09-07-2020 | - |
Independent Dir/Board Member | 09-07-2020 | - |
Opleiding van H. Shepard
Indiana University | Doctorate Degree |
University of California, Davis | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Chief Tech/Sci/R&D Officer | 5 |
President | 3 |
Founder | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
NEVIS BRANDS INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
NewBiotics, Inc.
NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology NewBiotics, Inc. develops pharmaceutical drugs to treat cancer and infectious disease. It applies its Enzyme Catalyzed Therapeutic Activation technology to develop pharmaceuticals that transform drug resistance into therapeutic advantage. The company was founded by H. Michael Shepard and Geoffrey Myles Wahl in 1997 and is headquartered in San Diego, CA. | Health Technology |
Receptor BioLogix, Inc.
Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Health Technology |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Health Services |
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Health Technology |
- Beurs
- Insiders
- H. Shepard
- Ervaring